BREAKING NEWS: Merck & Co. Leaps Into COPD Space With $10bn Verona Buy
The UK firm's chronic obstructive pulmonary drug Ohtuvayre has been enjoying a stellar launch.| Insights
The UK firm's chronic obstructive pulmonary drug Ohtuvayre has been enjoying a stellar launch.| Insights
